Fish Oil Omega-3: A Promising Treatment for Blindness
What is Fish Oil Omega-3?
Fish Oil Omega-3: A Promising Treatment for Blindness |
Blindness: Causes and signs
Blindness is a medical condition characterized by significant visual impairment, which may range from partial to complete loss of vision.
It can be caused by a variety of factors, such as damage to the eye or optic nerve, certain medical conditions, or genetic factors.
A person who is blind may have no visual perception at all or may have some limited vision, such as the ability to see only light and dark, shapes or shadows. Blindness can have a significant impact on a person's ability to perform daily activities and can require specialized training or assistance to live independently.
Blindness Treatment By Fish Oil Omega-3
Fish oil supplements contain Omega-3, a type of crucial fatty acid that the body needs to perform many essential functions. According to a study, taking fish oil supplements may contain the key to treating one of the main sources of blindness in the world.
An innovative form of Omega-3 fatty acids has been created by researchers that can penetrate the eye and prevent vision loss brought on by diseases like diabetes, Alzheimer's disease, and other ailments.
The supplement was able to travel through the intestines, penetrate the bloodstream, reach the retina, and then exit the retina in a rodent trial. By doing this, age-related ocular degeneration is avoided. Docosahexaenoic acid (DHA), a type of omega-3 created in a lab, was able to travel from the circulation to the retina and was capable of being absorbed from the gut into the bloodstream, in contrast to the type of omega-3 that is typically found in fish oil supplements today.
Omega-3 fatty acid intake is being studied by experts to see if it can stop vision loss because AMD is a common source of significant vision loss in the elderly. A form of retinal degeneration is AMD. There are no medications on the market right now to address AMD.
Fish oil and krill oil products contain triacylglycerol (TAG) DHA, a type of DHA that cannot cross the blood-retinal barrier. "This approach provides a novel therapeutic approach to prevent or mitigate retinal impairment associated with Alzheimer's disease and diabetes," says Professor Sugasini Dhavamani, MD, of the University of Illinois at Chicago.
The article's primary source was the Department of Medicine at the University of Chicago. There have not yet been any studies on this particular Omega-3 in people. DHA levels in rodent retinas improved by 96% after six months of daily LPC-DHA administration, and retinal anatomy and function were preserved.
However, TAG-DHA consumption had no impact on the quantity or effectiveness of DHA in the eye. DHA is primarily found in the retina of healthy eyes, where it supports the health of the photoreceptors—the cells that transform light into messages for the brain. Healthy amounts of DHA in the retina shield it from the harmful impacts of reactive stress and intense light.
Additionally, recent studies have demonstrated that individuals with greater blood levels of DHA are better protected against brain disorders like Alzheimer's and others.
The quantity of Omega-3 fatty acids recommended by their LPC-DHA dose is roughly equal to what the American Heart Association and the US National Institutes of Health advise for daily intake: 250 to 500 milligrams.
The specialists who will share their findings this week at the American Society for Biochemistry and Molecular Biology's annual meeting say that more research will be needed. Further study will be necessary to determine whether LPC-DHA is safe for use in humans, they noted.
Post a Comment